| Identification | Back Directory | [Name]
N-[5-(1H-imidazol-2-yl)-2,4-dimethylphenyl]-4-[(pyridin-2-yl)methoxy]benzamide | [CAS]
1126366-28-6 | [Synonyms]
AZD7254 Benzamide, N-[5-(1H-imidazol-2-yl)-2,4-dimethylphenyl]-4-(2-pyridinylmethoxy)- N-[5-(1H-imidazol-2-yl)-2,4-dimethylphenyl]-4-[(pyridin-2-yl)methoxy]benzamide | [EINECS(EC#)]
682-708-5 | [Molecular Formula]
C24H22N4O2 | [MOL File]
1126366-28-6.mol | [Molecular Weight]
398.46 |
| Hazard Information | Back Directory | [Uses]
AZD7254 is an orally active Smoothened (SMO) inhibitor with an EC50 of 1.0 nM against sonic Hh protein (shh)[1]. | [in vivo]
AZD7254 (40 mg/kg; p.o.; twice daily for 10 days) exhibits 42% tumor growth inhibition in an HT29-MEF (murine embryonic fibroblast) co-implant xenograft model[1]. | [References]
[1] Yang B, et al. Heteroarylamide smoothened inhibitors: Discovery of N-[2,4-dimethyl-5-(1-methylimidazol-4-yl)phenyl]-4-(2-pyridylmethoxy)benzamide (AZD8542) and N-[5-(1H-imidazol-2-yl)-2,4-dimethyl-phenyl]-4-(2- pyridylmethoxy)benzamide (AZD7254). Bioorg M DOI:10.1016/j.bmc.2019.115227 |
|
| Company Name: |
ChemOrigin Pharm
|
| Tel: |
15026428026 19002516454 |
| Website: |
chemorigin.com/ |
|